Research Faculty

Richard L Bennett

Richard L Bennett, PhD

Research Assistant Professor
Phone: (352) 273-8333

I first became interested in molecular and cellular biology as an undergraduate at Kalamazoo College, and later, as a graduate student at Weill Cornell Graduate School of Medical Sciences, I decided to devote my career to researching the molecular basis of cancer. This has provided me with the opportunity to study interesting questions that are both fundamental to biology and also of significance to our society. After graduate school, I worked first as a post-doctoral fellow and then as a Research Assistant Professor to determine the role of the interferon-inducible, dsRNA-activated protein kinase PKR in tumorigenesis. In 2016 I had the opportunity to join the Research group of Jonathan Licht, M.D. to study the role of chromatin dynamics in cancer. My projects in the Licht lab include: characterizing how histone mutations that disrupt nucleosome structure may cause changes in gene expression that drive the tumorigenic phenotype, analyzing the mechanism by which an activating mutation of the histone methyltransferase NSD2 dysregulates the chromatin landscape to drive myeloma or ALL and identifying new genetic vulnerabilities in uveal melanoma.

Christopher R Cogle

Christopher R Cogle, M.D.

Professor Of Medicine
Phone: (352) 273-7493

Dr. Cogle is a professor of medicine, as well as a physician-scientist with clinical and research expertise in the myelodysplastic syndromes, acute leukemias, and bone marrow failure syndromes. He uses blood & marrow transplantation as a treatment option for patients who need more than chemotherapy to eradicate disease. Dr. Cogle also runs a stem cell research laboratory where he dissects the mechanisms of bone marrow-derived blood vessels. His research has made significant impact in the fields of cancer and cardiology. Dr. Cogle’s overall goal is to design safer and more effective methods of treating diseases by tapping into the potential of hematopoietic stem and progenitor cells.

  • Alpha Omega Alpha
    1998 · Alpha Omega Alpha
  • NIH Loan Repayment Award
    2002 · NIH
  • Young Investor Award
    2003 · American Society of Clinical Oncology
  • First Prize in Research
    2004 · Joint Cancer Conference of the Florida Universities
  • Top 10 US Young Stem Cell Scientist
    2005 · British Council
  • Best in Research
    2006 · University of Florida
  • Excellence in Teaching Award
    2008 · University of Florida
  • Center of Excellence in Myelodysplastic Syndromes
    2009 · MDS Foundation
  • Best in Research
    2011 · University of Florida
  • Scholar in Clinical Research
    2012 · Leukemia and Lymphoma Society
  • Bench to Bedside Award
    2012 · University of Florida
Coy Heldermon

Coy Heldermon, M.D., Ph.D.

Phone: (352) 273-8008

Dr. Heldermon is an associate professor of medicine, board certified medical oncologist with expertise in the treatment of breast cancer. He is a member of the American Society of Hematology and the American Society of Clinical Oncology. His research expertise is in the use of gene replacement and stem cell therapies for the treatment of inherited disorders such as lysosomal storage diseases. He also studies the spread of stem cells from maternal or malignant sources using mouse models.

Frederic J Kaye

Frederic J Kaye, M.D.

Phone: (352) 273-7766

Dr. Kaye is a professor of medicine, medical director of the thoracic oncology program and director of the lung cancer center within the division of hematology and oncology. He is a clinical and basic science investigator with a focus on thoracic malignancies. Dr. Kay is an elected member of the American Society for Clinical Investigation, the Alpha Omega Alpha medical honor society, and serves as Associate Editor of the Journal of the National Cancer Institute.

Jonathan D Licht

Jonathan D Licht, MD

Phone: (352) 273-8143

Dr. Licht is the director of the UF Health Cancer Center, holding the Marshall E. Rinker, Sr. Foundation and David B. and Leighan R. Rinker Chair. Previously Dr. Licht was Chief of Hematology/Oncology at Northwestern University and an Associate Director of the Robert H. Lurie Comprehensive Cancer Center. NCI funded for nearly 25 years, Dr. Licht is also Principal Investigator of a Leukemia and Lymphoma Society Specialized Center and a Multiple Myeloma Research Foundation program grant. He is an investigator in the Dana-Farber SPORE in myeloma and co-leader in a NCI-funded Chicago Physical Sciences Oncology Center. Senior Editor of Clinical Cancer Research, Dr. Licht serves on the editorial boards of Oncogene and Cancer Cell. He’s a member of the executive committee of the American Society of Hematology, and will be co-director of the 2017 ASH/EHA Translational Research Training program. Additionally he sits on the Medical/Scientific Board of the LLS and is a member of the Basic Mechanisms of Cancer Therapeutics Study Section. Dr. Licht has published nearly 170 original articles, reviews and book chapters, and mentors graduate students, postdoctoral fellows and faculty members.

Zhijian Qian

Zhijian Qian, PhD

Phone: (352) 273-7832